The Mind&Market de Bruxelles event is a key platform for startups and innovative entrepreneurs. MJ Pharma stood out by winning an award, confirming the relevance of our project in the pharmaceutical industry. Currently under development, the MJ Pharma app will soon be available in beta.
A demanding competition where MJ Pharma made a difference
Every year, Mind&Market brings together hundreds of startups, offering entrepreneurs a platform to pitch their ideas, convince investors, and exchange with industry experts.
A rigorous selection process
The event relies on a panel of experts who evaluate projects based on several criteria:
- Innovation and market impact
- Economic potential and scalability
- Technical feasibility and regulatory compliance
MJ Pharma successfully met these requirements with a solution that revolutionizes the management of unsold pharmaceutical products and optimizes pharmacies’ profitability. Although the app is not yet launched, it will soon enter the beta testing phase to validate its efficiency.
MJ Pharma: a solution addressing market challenges
The pharmaceutical market faces complex stock management issues, with an estimated 5 to 10% of unsold inventory, according to various studies. These losses represent a significant financial shortfall for pharmacies, as some medications expire before being sold.
An innovative and responsible concept
MJ Pharma tackles these issues with a pharmacy-to-pharmacy resale platform, allowing:
- The revaluation of unsold stock, reducing financial losses
- An eco-friendly approach, preventing unnecessary drug destruction
- Automation of regulatory aspects, ensuring full compliance with legal requirements
📌 Relevant legislation: In Belgium, the management of unsold medications is governed by the Royal Decree of December 14, 2006, which mandates pharmacies to follow strict protocols for storage and redistribution of pharmaceutical products.
The impact of Mind&Market on MJ Pharma’s growth
Winning an award at Mind&Market is more than just a trophy:
- Enhanced credibility with investors and partners
- Accelerated development thanks to expert feedback
- Funding opportunities to optimize the scalability of the platform
A project in the validation phase
The MJ Pharma app is still under development and will soon be available in beta. This phase is crucial to:
- Test the user experience and service reliability
- Gather user feedback before the official launch
- Finalize integration of legal and technical requirements
📊 Industry data: According to a study by Pharma Belgium, nearly 15% of medications ordered annually remain unused in some pharmacies. Optimized stock management could reduce these losses by over 40%. (Source: Pharma Belgium 2023)
A promising future for MJ Pharma with an upcoming beta launch
Winning at Mind&Market marks a major milestone, but the journey is just beginning. With the upcoming beta version, MJ Pharma enters a critical phase to refine its solution before a broader rollout.
🎯 The goal is clear: finalize the app, collect valuable feedback, and offer pharmacies a powerful tool to efficiently manage unsold stock.